Upward share price momentum continues at Windar Photonics (LON: WPHO) on the back of additional test orders for LiDAR wind sensor technology from Vestas. Also, non-executive director Paul Hodges bought 195,000 shares at 19.5538p each. The share price rose a further 163% to 21p and it is 20% higher over the year – making it one of the top 100 AIM performers in 2022.
Infrastructure India (LON: IIP) says it expects to receive proceeds from the sale of Indian Energy in December. The buyer has asked for additional time to complete the transaction and there is a possibility that the deal might not go through, and an alternative buyer comes forward. When cash is received it will be used to pay creditors. Other disposals are planned. The share price recovered by 38.5% to 0.45p.
Digital services provider TPXimpact (LON: TPX) rose 36.6% to 56p, following the publication of interim results that were no worse than expected. The underlying pre-tax fell from £4.7m to £400,000 and the interim dividend was maintained at 0.3p a share. The full integration of past acquisitions by the new management is continuing. A full year pre-tax profit of £5.45m is forecast.
Positive trial results for KidneyIntelX announced yesterday have boosted the share price of diagnostics firm Renalytix (LON: RENX) by 29.6% to 87.5p. KidneyIntelX has enabled early intervention with patients before kidney disease reaches a critical point. FDA approval is possible in the next few months.
Director buying at Primorus Investments (LON: PRIM) pushed the share price 28.3% higher at 2.95p. Executive chairman Rupert Labrum acquired one million shares at 2.86p each, taking his stake to 218%, and the wife of Hedley Clark purchased 784,791 shares at 2.53p each.
==========
Fallers
Falkland Islands oil and gas explorer Borders & Southern (LON: BOR) is raising £2.5m at 1.75p a share to finance studies of its 100%-owned Darwin gas condensate discovery. The previous market price was 3.15p and the share price has subsequently fallen 38.4% to 1.8775p.
ReNeuron (LON: RENE) is the latest small company to try to raise cash but find that market conditions mitigate against any fundraise. Cost savings are being made by the exosomes technology company so that the existing cash can last until the fourth quarter of 2023. Revenues are growing and the interim loss was reduced. The cash outflow from operating activities was £4.3m, while there was still £10.5m in the bank at the end of September 2022. The share price dived 37.6% to 15.3p.
Covid lockdowns in China have hit demand for kettle controls supplier Strix (LON: KETL). Zeus has reduced its 2022 pre-tax profit forecast by 17% to £23.2m and cut the 2023 figure by 11% to £29.7m. There could be some upside from the recently acquired water appliance manufacturer Billi. The share price, which had been recovering, dived 34.8% to 81.3p.
Drilling delays at five development Russian wells continue to push the Petroneft Resources (LON: PTR) share price lower and it declined by further one-third to 0.3p.
Because announcements were made late at the end of the previous week there was a delayed reaction to news from energy efficiency as a service provider eEnergy Group (LSE: EAAS) that is had raised £2.525m of subordinated debt lasting until 2024 issued at a discount. That discount equates to 2% repayment fee and 1.25% interest each month. The share price slumped 31.7% to 4.1p. Existing shareholder Hawk Investment, a company owned by John Foley, who will become a non-executive director, and eEnergy directors are providing the debt. There will be 42.1 million warrants with an exercise price of 6p – the current share price – issued to the lenders. It is taking longer to collect cash. Last year’s figures were in line with the previous trading statement. Net debt was £3.2m at the end of June 2022. First quarter revenues were 90% ahead at £7.6m.
